Orally Active Fusion Inhibitor of Respiratory Syncytial Virus
BMS-433771 was found to be a potent inhibitor of respiratory syncytial virus (RSV) replication in vitro. It exhibited excellent potency against multiple laboratory and clinical isolates of both group A and B viruses, with an average 50% effective concentration of 20 nM. Mechanism-of-action studies d...
Salvato in:
| Pubblicato in: | Antimicrob Agents Chemother |
|---|---|
| Autori principali: | , , , , , , , , , , , , , , , , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American Society for Microbiology (ASM)
2004
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC321540/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/14742189/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.48.2.413-422.2004 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
